title: Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity.
abstract: Cholera toxin (CT), the most commonly used mucosal adjuvant in experimental animals, is unsuitable for humans because of potent diarrhea-inducing properties. We have constructed two CT-A subunit mutants, e.g., serine-->phenylalanine at position 61 (S61F), and glutamic acid-->lysine at 112 (E112K) by site-directed mutagenesis. Neither mutant CT (mCT), in contrast to native CT (nCT), induced adenosine diphosphate-ribosylation, cyclic adenosine monophosphate formation, or fluid accumulation in ligated mouse ileal loops. Both mCTs retained adjuvant properties, since mice given ovalbumin (OVA) subcutaneously with mCTs or nCT, but not OVA alone developed high-titered serum anti-OVA immunoglobulin G (IgG) antibodies (Abs) which were largely of IgG1 and IgG2b subclasses. Although nCT induced brisk IgE Ab responses, both mCTs elicited lower anti-OVA IgE Abs. OVA-specific CD4+ T cells were induced by nCT and by mCTs, and quantitative analysis of secreted cytokines and mRNA revealed a T helper cell 2 (Th2)-type response. These results now show that the toxic properties of CT can be separated from adjuvanticity, and the mCTs induce Ab responses via a Th2 cell pathway.
authors.affiliation: Immunobiology Vaccine Center and Department of Microbiology, University of Alabama at Birmingham, 35294, USA.
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Takeda
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
authors.forename: H
authors.initials: H
authors.lastname: Kurazono
authors.forename: K
authors.initials: K
authors.lastname: Imaoka
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
authors.forename: K
authors.initials: K
authors.lastname: Fujihashi
authors.forename: M
authors.initials: M
authors.lastname: Noda
authors.forename: H
authors.initials: H
authors.lastname: Kiyono
authors.forename: J R
authors.initials: JR
authors.lastname: McGhee
mesh_terms: D000276:Adjuvants, Immunologic / Q000633:toxicity*; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016466:CHO Cells; D002772:Cholera Toxin / Q000235:genetics / Q000633:toxicity*; D006224:Cricetinae; D000242:Cyclic AMP; D016207:Cytokines / Q000096:biosynthesis; D003967:Diarrhea; D004305:Dose-Response Relationship, Drug; D007082:Ileum / Q000187:drug effects; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D009092:Mucous Membrane / Q000276:immunology; D009154:Mutation; D011065:Poly(ADP-ribose) Polymerases / Q000235:genetics*; D018418:Th2 Cells / Q000276:immunology; D018675:Toxicity Tests
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D002772:Cholera Toxin; D000242:Cyclic AMP; D011065:Poly(ADP-ribose) Polymerases